Informations sur le produit
Trans-Ned 19 is a dinucleotide phosphate that has been shown to inhibit intracellular Ca2+ levels. It has been studied as a potential anticancer agent in animal models and is also being investigated for use in the treatment of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. Trans-Ned 19 is an acidic compound, which may be due to its ability to modulate mitochondrial membrane potential. This agent can inhibit glutamate-induced cytosolic Ca2+ release and autophagy in cardiomyocytes, which may contribute to its anticancer activity.